Is ORIC Pharmaceuticals, Inc. (ORIC) a Buy, Sell, or Hold?
NASDAQ : ORIC
ORIC Pharmaceuticals, Inc. — Analyst Ratings
$12.1 USD
$1.21 (11.11%)
- Volume
- 3.61M
- Average Volume
- 1.62M
- Market Capitalization
- $1.25B
- P/E Ratio
- -8.40
- Dividend Yield
- 0.00%
- Price Target
- $15.00
- Year High
- $14.93
- Year Low
- $7.23
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $16.33
Analyst Consensus Summary
Consensus Rating
Sell
10 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-19.3%
vs Current Price
Price Target
$15.00
Average TargetPrice Target Range
Lowest Target
$15.00
-19.3% DOWNSIDE
Average Target
$15.00
Median Estimate
Highest Target
$25.00
-51.6% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 10
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 10 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Robert Burns | $25 | $13.2661 | 2026-02-24 10:50 AM | 88.5% |
| Oppenheimer | Matthew Biegler | $15 | $11.71 | 2026-02-24 12:34 AM | 28.1% |
| Piper Sandler | Kelsey Goodwin | $22 | $8.14 | 2026-01-07 05:19 AM | 170.3% |
| Guggenheim | Brad Canino | $18 | $10.6 | 2025-09-04 05:21 AM | 69.8% |
| Oppenheimer | Matthew Biegler | $12 | $5.04 | 2025-05-06 07:45 AM | 138.1% |
| Stifel Nicolaus | Bradley Canino | $20 | $9.48 | 2024-09-05 12:13 PM | 111.0% |
| H.C. Wainwright | Robert Burns | $21 | $14.59 | 2024-03-21 02:32 AM | 43.9% |